Ranked on: #23 Top VC Firms in Boston 2026 (Ranked by Deals) · #166 Most Active Series B Investors of 2026 (Ranked) · Get your badge →
Is this your firm? Get featured or correct your listing →
Strategy
Stages
SeedSeries ASeries B
Sectors
HealthcareEnterprise
Geographies
USABoston, United States
Check size
$1M-$50MRecent changes
- Oct 13, 2026Oct 13, 2026Invested in Souffle Therapeutics (Series B, $135M) FinancialContent
Portfolio
1 totalRecent Investment Activity
1Track record: led 0 and participated in 1 of 1 tracked venture round · 1 in the last 12 months
| Date | Company | Event | Role | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|---|---|
| Oct 13, 2026 | Souffle Therapeutics | Series B | Participated | $135M | — | Fidelity InvestmentsunverifiedARCH Venture PartnersunverifiedBessemer Venture PartnersunverifiedJanus Henderson InvestorsunverifiedLeaps by BayerunverifiedPolaris PartnersunverifiedTemasekunverifiedVida VenturesunverifiedJuvia GroupTCG Crossover ManagementBB BiotechBalyasny Asset Management+5 more | FinancialContent |
Co-Investors
7Similar Firms
overlapping sector, stage or regionValue Add Research
Latest Pulse
- Oct 13, 2026TRexBio Closes $116.7M IPO, Lilly Eyes Bigger StakeTRexBio closed its IPO on Oct. 13, selling 8.33 million shares at $14 for about $116.7 million, with largest shareholder Eli Lilly signaling interest in raising its stake.→
- Oct 13, 2026Souffle Therapeutics Raises $135M For RNA TherapiesSouffle Therapeutics closed an oversubscribed $135 million Series B led by Juvia Group on Oct. 13 to push its RNA-delivery platform's first three programs toward the clinic.→
Polaris Partners FAQ
What companies has Polaris Partners invested in?
Polaris Partners' portfolio includes Souffle Therapeutics.
Who does Polaris Partners co-invest with most?
In the rounds Value Add tracks, Polaris Partners most often invests alongside ARCH Venture Partners (1 shared deal), Bessemer Venture Partners (1 shared deal), Fidelity Investments (1 shared deal), Janus Henderson Investors (1 shared deal), Leaps by Bayer (1 shared deal).
Sources & methodologyshow
Where these figures come from
- FinancialContentresearch database1 fact
Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.